APPLICATION
ANDA210805
TYPE
ANDA
ROUTE
ORAL
DOSAGE FORM
CAPSULE, EXTENDED RELEASE
MARKETING STATUS
None (Tentative Approval)
Products
LEVOMILNACIPRANNone (Tentative Approval)
LEVOMILNACIPRAN 40MG · CAPSULE, EXTENDED RELEASE · ORAL
LEVOMILNACIPRANNone (Tentative Approval)
LEVOMILNACIPRAN 80MG · CAPSULE, EXTENDED RELEASE · ORAL
LEVOMILNACIPRANNone (Tentative Approval)
LEVOMILNACIPRAN 20MG · CAPSULE, EXTENDED RELEASE · ORAL
LEVOMILNACIPRANNone (Tentative Approval)
LEVOMILNACIPRAN 120MG · CAPSULE, EXTENDED RELEASE · ORAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.